Delivery Order SPE2DB22D2206-SPE2DB25FDV38

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIGAMOX 0.5% eye drops, with a ceiling value of $3,439.03 and a completion date of November 22, 2023. The contract is a firm-fixed price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,283.03, is for the supply of VIGAMOX 0.5% eye drops with an ultimate completion date of January 23, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,784.03, is for the supply of VIGAMOX 0.5% eye drops. The delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,901.26, is for the supply of VIGAMOX 0.5% eye drops (3ml) to support military healthcare programs. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type....
This federal contract award, valued at $4,967.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VIGAMOX 0.5% eye drops, a medication used to treat eye infections. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 9, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award, valued at $3,315.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 3, 2025 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside...
This federal contract award, valued at $3,748.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of February 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of VIGAMOX 0.5% eye drops (3ml) to support military treatment programs and facilities. The contract has a ceiling value of $3,993.12 and a performance period through March 15, 2024....
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,109.20, is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 13, 2024. This award is not associated with a set-aside...
This federal contract award is for the delivery of VIGAMOX 0.5% eye drops in 3ml quantities to the Medical Supply Chain, which is an organization under the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 24, 2024, with a ceiling value of $2,218.40. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 25, 2024. This...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDV38
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of VIGAMOX 0.5% eye drops in a 3ml size. The total ceiling value of the contract is $11,010.11, and it is a firm fixed-price contract type with an ultimate completion date of October 18, 2024. This contract award is a child of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 1/16/25, 9:15 AM